摘要
目的:以体外培养的单核细胞系为研究对象,从细胞水平探讨血管紧张素Ⅱ对CD40信号系统的影响。方法:用1640培养液进行单核细胞的培养,并用佛波醇肉豆蔻乙酸酯(PMA)诱导其分化为巨噬细胞。将培养的细胞置于不同浓度的血管紧张素Ⅱ(10-10~10-5mol/L)及拮抗剂氯沙坦、PD123319中培养24 h,用实时聚合酶链反应(PCR)的技术检测细胞CD40mRNA的变化;同时酶联免疫法测定细胞上清分泌的CD40蛋白水平。结果:给予PMA(50ng/ml)刺激4 h后,单核细胞贴壁分化为巨噬细胞,与不同浓度血管紧张素Ⅱ(10-10~10-5mol/L)共培养24 h后,与对照组相比较,血管紧张素Ⅱ的10-6mol/L组与10-5mol/L组CD40 mRNA的表达均明显增加(P均〈0.05);受体AT1拮抗剂氯沙坦(25μg/ml)抑制了CD40 mRNA的表达,另一受体AT2拮抗剂PD123319(25μg/ml)显示了明显的相反作用(P〈0.05)。含单核细胞分化成的巨噬细胞上清液中CD40蛋白水平在血管紧张素Ⅱ及其受体拮抗剂的刺激下显示与CD40 mRNA水平一致的结果。结论:血管紧张素Ⅱ对于单核细胞转化生成的巨噬细胞CD40-CD40L系统的表达具有上调作用。血管紧张素Ⅱ两种受体拮抗剂对CD40系统的作用不同,提示肾素-血管紧张素系统与CD40信号系统之间具有一定相互作用。
Objective:To investigate the influence of angiotensin Ⅱ(AngⅡ) on CD40 signaling system in THP-1 monocyte cell line and macrophages.Methods:THP-1 monocyte cells were cultured in 1640 medium and induced to macrophages by phorbol myristate acetate(PMA).Then the macrophages were cultured in medium containing AngⅡ(10-10~10-5mol/L) and antagonist losartan,PD123319 for 24h.CD40 mRNA level was analyzed by real-time Taqman polymerase chain reaction(PCR).And supernatant CD40 level was examined by enzyme-linked immunosorbent assay.Results:THP-1 monocyte cells were induced to macrophages by PMA(50ng/ml) after 4h.After exposed to varied concentrations of AngⅡ(10-10~10-5mol/L)for 24h,expressions of CD40 mRNA in AngⅡ10-6mol/L group and 10-5mol/L group significantly increased compared with control group(P0.05 both);AT1 antagonist losartan(25μg/ml) inhibited the expression of CD40 mRNA whereas AT2 antagonist PD123319(25μg/ml) showed significant opposite effect(P0.05).After exposed to AngⅡ and its antagonists,CD40 protein levels of supernatant of macrophages showed results parallel to those of CD40 mRNA levels.Conclusion:Angiotensin Ⅱ enhanced the expression of CD40 signalling system in macrophages;two kinds of AT receptor antagonists showed opposite effects on CD40 system.It indicates some relationship between renin-angiotensin-system and CD40 signalling system.
出处
《心血管康复医学杂志》
CAS
2011年第1期18-21,共4页
Chinese Journal of Cardiovascular Rehabilitation Medicine
基金
陕西省卫生厅科研基金(08D39)